Fidelity European Trust May Factsheet – European equities moved higher

Fidelity

Fidelity European Trust PLC (LON:FEV) monthly factsheet for May 2025.

Portfolio Manager Commentary

European equities ended the month higher, navigating a period of heightened volatility as investors weighed in uncertainty surrounding US trade policies.  

The Trust underperformed the index during the month, primarily due to weak positioning in the consumer staples and consumer discretionary sectors, while gearing had a small positive impact. Shares in 3i Group declined following the release of full-year results to 31 March 2025. Despite a 22% increase, the net asset value (NAV) growth fell short of market expectations. Action, 3i’s largest portfolio company, continued to perform well. Shares in L’Oréal were weak in the absence of any positive catalysts during the month. In contrast, ABN AMRO Bank was a key contributor to performance. The company’s shares advanced following the first quarter of the year 2025 results that were broadly in line with expectations. The holding in Legrand was a top contributor – the stock gained after the company delivered strong first quarter 2025 results, with organic sales surpassing consensus expectations.  

Our focus is on finding attractively valued companies with good prospects for cash generation and dividend growth over the longer term. On a rolling 12-month basis, the Trust recorded NAV and share price returns of 2.8% (net of fees) and 3.5% respectively, compared to the FTSE World Europe ex UK Total Return Index that returned 7.4%.

Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Strategic shifts and utility gains steady European markets

European markets continue to evolve in response to complex global drivers that influence risk appetite and corporate performance.

Capture growth investment opportunities in Europe in 2026

Portfolio managers Sam Morse and Marcel Stötzel outline why they continue to see opportunity in Europe in 2026.

European stocks climb as defence takes centre stage in investor positioning

European stocks climb as investors rotate into defence, responding decisively to rising geopolitical risk.

European Investment Trust performance boosted by Roche drug trial success (LON: FEV)

Continental European markets delivered positive returns in November. Fidelity European Trust saw encouraging contributions from Roche and ABN AMRO and remains positioned for long-term growth through disciplined stock selection and a focus on sustainable cash flows.

European equities hold ground ahead of policy shifts

European equities edge up as investors navigate a week of policy signals and key data with deliberate caution.

European defence stocks climb on German procurement momentum

Germany’s military procurement plans have kicked defence stocks into motion, giving investors a clearer signal on where the capital is headed.

Search

Search